A clinical trial studying teduglutide in Japanese people with short bowel syndrome was updated on August 7, 2026. The study, titled "A Study of Teduglutide in Japanese People With Short Bowel Syndrome" and registered as NCT05023382, is now listed with a status of completed.
The trial record does not specify a phase designation in the data available. No results, outcomes, or efficacy data are included in this status update.
Teduglutide is an approved compound. This update reflects only a change in the trial's recorded status on clinicaltrials.gov and does not indicate what, if any, findings were observed.
Readers interested in additional detail can consult the trial listing directly for further information as it becomes available. For more background on this compound, see the linked compound overview.</body_markdown>
<parameter name="sources">["https://clinicaltrials.gov/study/NCT05023382"]